ArticleNeuro-oncology advances

Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.

Mame Daro Faye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.